← back to search

Elizabeth L. Barry

Dartmouth College · US
Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Colorectal Cancer Screening and Detection, Cancer, Lipids, and Metabolism, Vitamin D Research Studies, and Inflammatory mediators and NSAID effects.
h-index
37
citations
5,109
works
262
NIH funding
primary concept
email

Recent publications

Using gene-environment interactions to explore pathways for colorectal cancer risk
EBioMedicine 2025cited by 2position: middledoi
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer
Science Advances 2024cited by 6position: middledoi
Genetic Variation and Regulation of MICA Alters Natural Killer Cell-Mediated Immunosurveillance in Early-Onset Colorectal Cancer
medRxiv 2024cited by 0position: middledoi
A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
Cancer Research 2023cited by 14position: middledoi
Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses
British Journal of Cancer 2023cited by 14position: middledoi
Genome-wide interaction analysis of folate for colorectal cancer risk
American Journal of Clinical Nutrition 2023cited by 11position: middledoi
Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
Cancer Epidemiology Biomarkers & Prevention 2023cited by 6position: middledoi
Plasma Metabolomics Analysis of Aspirin Treatment and Risk of Colorectal Adenomas
Cancer Prevention Research 2022cited by 22position: firstdoi
Inflammation Modulation by Vitamin D and Calcium in the Morphologically Normal Colorectal Mucosa of Patients with Colorectal Adenoma in a Clinical Trial
Cancer Prevention Research 2020cited by 36position: middledoi
Effects of supplemental calcium and vitamin D on tight‐junction proteins and mucin‐12 expression in the normal rectal mucosa of colorectal adenoma patients
Molecular Carcinogenesis 2019cited by 45position: middledoi
No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial
Cancer Prevention Research 2019cited by 33position: lastdoi
Novel Common Genetic Susceptibility Loci for Colorectal Cancer
JNCI Journal of the National Cancer Institute 2018cited by 190position: middledoi
Abstract GS4-07: Results from a randomized placebo-controlled phase 2 trial evaluating exemestane ± enzalutamide in patients with hormone receptor–positive breast cancer
Cancer Research 2018cited by 33position: middledoi
Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome
Gastroenterology 2017cited by 86position: middledoi
Vitamin D Receptor Genotype, Vitamin D<sub>3</sub> Supplementation, and Risk of Colorectal Adenomas
JAMA Oncology 2016cited by 91position: firstdoi
Effects of supplemental calcium and vitamin D on the APC/β‐catenin pathway in the normal colorectal mucosa of colorectal adenoma patients
Molecular Carcinogenesis 2016cited by 26position: middledoi
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas
New England Journal of Medicine 2015cited by 318position: middledoi
Urinary Metabolites of Prostanoids and Risk of Recurrent Colorectal Adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS)
Cancer Prevention Research 2015cited by 277position: middledoi
Genetic Variants in<i>CYP2R1</i>,<i>CYP24A1</i>, and<i>VDR</i>Modify the Efficacy of Vitamin D<sub>3</sub>Supplementation for Increasing Serum 25-Hydroxyvitamin D Levels in a Randomized Controlled Trial
The Journal of Clinical Endocrinology & Metabolism 2014cited by 154position: firstdoi
Abstract CT335: A clinical trial of supplementation with vitamin D and/or calcium for the prevention of colorectal adenomas
Cancer Research 2014cited by 4position: middledoi
Vitamin D3 Supplementation and Upper Respiratory Tract Infections in a Randomized, Controlled Trial
Clinical Infectious Diseases 2013cited by 65position: middledoi
CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment
Cancer Causes & Control 2012cited by 15position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

John A. Baron · University of North Carolina at Chapel Hill13 papers (2012–2022)Roberd M. Bostick · Emory University10 papers (2013–2020)Dennis J. Ahnen · University of Colorado Denver7 papers (2012–2019)Leila A. Mott · Dartmouth College7 papers (2012–2022)Robert S. Sandler · University of North Carolina at Chapel Hill6 papers (2012–2017)Judy R. Rees · London School of Hygiene & Tropical Medicine5 papers (2013–2019)March E. Seabrook · University of South Carolina4 papers (2015–2020)Janet L. Peacock · Dartmouth College4 papers (2013–2022)Jane C. Figueiredo · University of Southern California4 papers (2014–2019)Veronika Fedirko · The University of Texas MD Anderson Cancer Center4 papers (2015–2022)Carol A. Burke · Cleveland Clinic4 papers (2014–2017)Douglas J. Robertson · Dartmouth College4 papers (2015–2019)Robin E. Rutherford · Emory University3 papers (2016–2020)Timothy R. Church · University of Minnesota3 papers (2014–2017) · 2 papers (2015–2017)Robert W. Summers · University of Iowa2 papers (2014–2015)Richard Rothstein · Dartmouth College2 papers (2014–2015)Marcia Cruz–Correa · Johns Hopkins Medicine2 papers (2015–2017)Anastasia Ivanova · State Research Center of the Russian Federation2 papers (2014–2015)Michael N. Passarelli · Dartmouth College2 papers (2019–2022)